Medigene AG

MDGEFOTCHealthcare● Active

$2.59

+$0.00(+0.00%)

Market Cap$38170366

P/E Ratio—

52W High$2.59

52W Low$0.1

Avg Volume6K

Open$2.59

Beta1.36

Overview

Medigene AG (MDGEF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MDGEF · free cash flow · updated Jun 15, 2026

Core FCF metrics

MDGEF · FCF · TTM · margin & CAGR

Free cash flow was −$15.8M for FY2023 (fiscal year ending 2023-12-31), down 243.9% year-over-year The FCF margin was -261.6%.

FY2023 Free Cash Flow−$15.8M▼ -243.9% YoY

Trailing 12M (TTM)−$29.2Mtrailing 4 quarters sum

FCF Margin-261.6%−$15.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MDGEF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2023Latest−$15.1M(1M)−$15.8M▼ 243.9%-261.6%

FY2022$12.0M(1M)$11.0M▲ +200.8%35.1%

FY2021−$10.8M(0M)−$10.9M▲ +56.9%-104.0%

FY2020−$24.8M(0M)−$25.3M▼ 41.6%-315.8%

FY2019−$16.4M(1M)−$17.9M▼ 60.0%-169.8%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MDGEF · P/FCF · FCF yield · FCF per share

Medigene AG (MDGEF) reported negative free cash flow of −$0.02B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-12-31

Cash flow statement summary

MDGEF · cash flow statement · operating / investing / financing

For FY2023, Medigene AG generated −$15.1M in operating cash flow and spent 1M in capital expenditures, yielding −$15.8M in free cash flow.

Operating Activities

−$15.1M

Cash from core business operations

2023-12-31

Investing Activities

+$2.4M

CapEx, acquisitions & investments

2023-12-31

Financing Activities

−$0.8M

Buybacks, dividends & debt

2023-12-31

FCF FormulaOperating CF (−$15.1M) − |CapEx| (1M) = FCF (−$15.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MDGEF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Medigene AGYOU

MDGEF

−$15.8M-243.9%-261.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Medigene AG (MDGEF) reported free cash flow of −$15.8M for FY2023 (fiscal year ending 2023-12-31), down 243.9% year-over-year. The FCF margin was -261.6%.

Based on available data, Medigene AG has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $11.0M in FY2022.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MDGEF free cash flow · 8 questions

Medigene AG free cash flow was −$15.8M for FY2023, down 243.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$29.2M.

MDGEF free cash flowMDGEF FCFMDGEF FCF 2023MDGEF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Medigene AG · Medigene AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026